(Q34157711)

31 July 2017

1 reference

title

Addiction pharmacotherapy 2000: new options, new challenges (English)

1 reference

31 July 2017

0 references

R A Rawson

1

1 reference

31 July 2017

M J McCann

series ordinal

2

1 reference

31 July 2017

A J Hasson

series ordinal

3

1 reference

31 July 2017

W Ling

series ordinal

4

1 reference

31 July 2017

publication date

1 October 2000

1 reference

Journal of Psychoactive Drugs

31 July 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

31 July 2017

volume

32

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

371-378

1 reference

Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400238

A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400238

Outpatient opiate detoxification treatment with buprenorphine. Preliminary investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400238

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400238

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400238

A 3-year progress report on the implementation of LAAM in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400238

Treatment for opioid dependence: quality and access

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400238

Preliminary assessment of a 10-day rapid detoxification programme using high dosage buprenorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400238

Clinical pharmacology of buprenorphine: ceiling effects at high doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2000.10400238

10.1080/02791072.2000.10400238

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference